MEDICAL CANNABIS FOR THE GERMAN MARKET

01 _ About the Project

Bavaria Weed GmbH is one of the first pharmaceutical companies to hold a manufacturing license for the unlimited import and refinement of cannabis raw materials in the European Union. Thanks to the in-house production, the company is able to acquire cannabis agricultural raw materials from approved manufacturers, to refine them into medical products, to package them and to sell them as pharmaceuticals to German pharmacies.

 

The sale of cannabis for medical purposes in Germany has been legal since March 2017 and is subject to strict regulations by the cannabis agency of the Federal Institute for Drugs and Medical Devices. Since then, medical cannabis has been available only in German pharmacies.

 

The limited number of producers and varieties as well as the legally required shelf life in connection with long transport routes means that hardly any stocks are available and supply bottlenecks can be expected permanently. The domestic German market therefore offers immense growth potential. This is exactly where Bavaria Weed comes in: As an importer, distributor and producer, Bavaria Weed, in close cooperation with renowned partners in medical cannabis, will pave the way into the German market and create clear added value for patients and pharmacists.

Explore
  • Company Foundation

    March 2018

  • Partner since

    June 2018

  • Management

    T. Hoffmann, S. Langer, S. Pötzsch

  • Form of Enterprise

    GmbH

  • Locations

    Herrsching, Leipheim

  • Industry

    Pharma

  • More Information

    bavariaweed.de

“We have been working with the Patentpool Group from starts, as we had to rely on a strong partner, especially in the seed phase of our company. Patentpool recognized our potential early on in the very young German market. ”

Thomas Hoffmann

CEO & Founder

02 _ Highlights

What distinguishes Bavaria Weed

DISTINGUISHING FEATURES OF BAVARIA WEED COMPETITIVE BUSINESS CASE

The rapidly growing German market since the legalization of medical cannabis in 2017 and the pioneering role of Bavaria Weed in this market creates an extremely competitive business case.

MANUFACTURING LICENSE & ORGANIC PRODUCTION

As a medical manufacturer and wholesaler, Bavaria Weed is subject to the highest production criteria and controls and, by purchasing organically and organically grown raw materials, creates only high-quality cannabis.

STRATEGIC ORIENTATION

Bavaria Weed's business model is promptly geared towards the in-house production and extraction of CBD and THC.

EXPERIENCE & KNOW HOW

Our experienced management team is strongly involved in the Bavaria Weed project and has been supporting the young company since its foundation.

LEAD INVESTOR

With more than 20 years of experience in management and financing of disruptive technologies, Patentpool is involved as lead investor and provides operational support to the company.

"When we got to know the young company Bavaria Weed in summer 2018, we knew immediately that this was a unique opportunity with high growth and revenues potential. We ensure that Bavaria Weed succeeds in entering the relatively young German market."

Dr. Heiner Pollert

CEO Patentpool Group

Other Projects